We are live on
!
Find out more
SAM
Strategy Asset Managers Portfolio holdings
AUM
$670M
1-Year Est. Return
34.04%
This Fund
S&P 500
This Quarter
Est. Return
+10.22%
1 Year Est. Return
+34.04%
3 Year Est. Return
+107.53%
5 Year Est. Return
+130.35%
10 Year Est. Return
+379.12%
AUM
$422M
AUM Growth
+$39.5M
(+10%)
Cap. Flow
+$5.79M
Cap. Flow
% of AUM
1.37%
Top 10 Holdings %
Top 10 Hldgs %
29.7%
Holding
240
New
12
Increased
81
Reduced
118
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$5.19M |
| 2 |
UnitedHealth
UNH
|
+$3.72M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.97M |
| 4 |
Dick's Sporting Goods
DKS
|
+$2.42M |
| 5 |
Air Products & Chemicals
APD
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$5.51M |
| 2 |
iShares US Medical Devices ETF
IHI
|
+$1.04M |
| 3 |
Medtronic
MDT
|
+$945K |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$672K |
| 5 |
Corning
GLW
|
+$633K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.31% |
| 2 | Industrials | 12.36% |
| 3 | Healthcare | 11.57% |
| 4 | Financials | 10.86% |
| 5 | Communication Services | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.68T
| $19.9M | 4.73% |
53,040
-454
| -0.8% | -$162K |
|
2
Broadcom
AVGO
$1.85T
| $16.9M | 4.01% |
151,580
-2,390
| -2% | -$226K |
|
3
JPMorgan Chase
JPM
$966B
| $12.4M | 2.93% |
72,683
+1,696
| +2% | +$257K |
|
4
Alphabet (Google) Class A
GOOGL
$4.22T
| $12.3M | 2.92% |
88,264
-1,217
| -1% | -$164K |
|
|
ROIC
5
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $12.3M | 2.91% |
876,179
| – | – |
|
6
Apple
AAPL
$4.46T
| $12.2M | 2.9% |
63,579
+667
| +1% | +$123K |
|
7
Lockheed Martin
LMT
$140B
| $11.6M | 2.75% |
25,600
+177
| +0.7% | +$78.4K |
|
8
Johnson & Johnson
JNJ
$629B
| $9.3M | 2.21% |
59,354
+372
| +0.6% | +$57K |
|
|
9
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| $9.22M | 2.18% |
19,389
+6,669
| +52% | +$2.97M |
|
10
Cisco
CSCO
$441B
| $9.07M | 2.15% |
179,484
+53
| +0% | +$2.71K |
|
11
Emerson Electric
EMR
$91B
| $8.99M | 2.13% |
92,412
-526
| -0.6% | -$48.2K |
|
|
12
Eli Lilly
LLY
$1.05T
| $8.82M | 2.09% |
15,129
+8,883
| +142% | +$5.19M |
|
13
Microchip Technology
MCHP
$42.5B
| $8.33M | 1.97% |
92,328
-1,190
| -1% | -$96.9K |
|
14
BP
BP
$110B
| $8.13M | 1.93% |
229,630
-6,078
| -3% | -$223K |
|
15
BHP
BHP
$220B
| $8.11M | 1.92% |
118,671
-1,153
| -1% | -$69.6K |
|
16
Chevron
CVX
$394B
| $7.89M | 1.87% |
52,922
-1,459
| -3% | -$221K |
|
17
Honeywell
HON
$74.3B
| $7.76M | 1.84% |
39,273
-77
| -0.2% | -$13.9K |
|
18
Berkshire Hathaway Class B
BRK.B
$1.08T
| $7M | 1.66% |
19,638
+38
| +0.2% | +$13.3K |
|
19
Arthur J. Gallagher & Co
AJG
$64.6B
| $6.92M | 1.64% |
30,776
-151
| -0.5% | -$35.8K |
|
20
General Dynamics
GD
$107B
| $6.69M | 1.59% |
25,769
-67
| -0.3% | -$16.3K |
|
21
Aon
AON
$75.5B
| $6.54M | 1.55% |
22,468
-200
| -0.9% | -$64K |
|
22
Intercontinental Exchange
ICE
$86.6B
| $5.94M | 1.41% |
46,275
-386
| -0.8% | -$43.8K |
|
23
Home Depot
HD
$338B
| $5.49M | 1.3% |
15,853
+2
| +0% | +$619 |
|
24
Texas Instruments
TXN
$254B
| $5.41M | 1.28% |
31,736
-568
| -2% | -$88K |
|
25
Becton Dickinson
BDX
$49.9B
| $5.32M | 1.26% |
21,837
-1,174
| -5% | -$289K |
|
Similar funds
TAP
CCM
BCP
BFA
AVM
FAM
MCO
CCG
Strategy Asset Managers's Q4 2023 Portfolio in Review
As of Q4 2023, Strategy Asset Managers held 240 positions worth $422M, up 10% from $382M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Strategy Asset Managers's Q4 2023 filing shows 12 new, 81 increased, 118 reduced and 12 closed positions. Its largest new stake was Dick's Sporting Goods: 19,908 shares worth $2.93M. The largest sale was Pfizer, an estimated $5.51M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.
- Strategy Asset Managers's largest Q4 2023 buy was Dick's Sporting Goods: 19,908 shares worth $2.93M.
- Strategy Asset Managers added most to Eli Lilly in Q4 2023, an estimated $5.19M increase.
- Strategy Asset Managers's biggest Q4 2023 reduction was Pfizer, cutting an estimated $5.51M.
- Strategy Asset Managers fully exited iShares US Medical Devices ETF in Q4 2023, selling an estimated $1.04M.
- Strategy Asset Managers's ten largest holdings make up 30% of its $422M portfolio in Q4 2023.
- Strategy Asset Managers opened 12 new positions and closed 12 in Q4 2023.
- Strategy Asset Managers's portfolio value rose 10% quarter-over-quarter to $422M.
Based on Strategy Asset Managers's 13F filing for Q4 2023, filed 12 Feb 2024.